False000031361600003136162024-05-072024-05-070000313616us-gaap:CommonStockMember2024-05-072024-05-070000313616dhr:A0.2SeniorNotesDue2026Member2024-05-072024-05-070000313616dhr:A2.1SeniorNotesDue2026Member2024-05-072024-05-070000313616dhr:A1.2SeniorNotesDue2027Member2024-05-072024-05-070000313616dhr:A0.45SeniorNotesDue2028Member2024-05-072024-05-070000313616dhr:A2.5SeniorNotesDue2030Member2024-05-072024-05-070000313616dhr:A0.75SeniorNotesDue2031Member2024-05-072024-05-070000313616dhr:A1.35SeniorNotesDue2039Member2024-05-072024-05-070000313616dhr:A1.8SeniorNotesDue2049Member2024-05-072024-05-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 7, 2024
__________________
dhrlogo.jpg
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
__________________
Delaware001-0808959-1995548
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701
Suite 800W
Washington,DC
(Address of Principal Executive Offices) (Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueDHRNew York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange
2.100% Senior Notes due 2026DHR 26New York Stock Exchange
1.200% Senior Notes due 2027DHR/27New York Stock Exchange
0.450% Senior Notes due 2028DHR/28New York Stock Exchange
2.500% Senior Notes due 2030DHR 30New York Stock Exchange
0.750% Senior Notes due 2031DHR/31New York Stock Exchange
1.350% Senior Notes due 2039DHR/39New York Stock Exchange
1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 



ITEM 5.07SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The Company’s annual meeting of shareholders was held on May 7, 2024. At the annual meeting, the Company’s shareholders voted on the following proposals:
1.    To elect the thirteen directors named in the Company’s proxy statement to terms expiring in 2025. Each nominee for director was elected by a vote of the shareholders as follows:
ForAgainstAbstainBroker
Non-Votes
Rainer M. Blair617,006,356 13,153,236 646,691 33,025,986 
Feroz Dewan617,006,321 12,629,522 1,170,440 33,025,986 
Linda Filler561,873,256 68,221,238 711,789 33,025,986 
Teri List489,612,702 140,186,350 1,007,231 33,025,986 
Jessica L. Mega, MD, MPH620,823,514 9,340,678 642,091 33,025,986 
Mitchell P. Rales595,648,504 34,352,691 805,088 33,025,986 
Steven M. Rales590,591,256 39,582,134 632,893 33,025,986 
Pardis C. Sabeti, MD, D. Phil593,094,641 37,057,769 653,873 33,025,986 
A. Shane Sanders497,919,918 131,876,005 1,010,360 33,025,986 
John T. Schwieters465,914,759 163,630,380 1,261,144 33,025,986 
Alan G. Spoon541,141,424 88,988,855 676,004 33,025,986 
Raymond C. Stevens, PhD499,219,288 130,608,366 978,629 33,025,986 
Elias A. Zerhouni, MD599,902,732 29,752,439 1,151,112 33,025,986 
2.    To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024. The proposal was approved by a vote of shareholders as follows:
For626,995,788 
Against35,879,628 
Abstain956,853 
3.    To approve on an advisory basis the Company’s named executive officer compensation. The proposal was approved by a vote of shareholders as follows:
For586,649,118 
Against41,950,464 
Abstain2,206,701 
Broker Non-Votes 33,025,986 
4.    To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 15%. The proposal was rejected by a vote of shareholders as follows:
For271,920,031 
Against357,574,684 
Abstain1,311,568 
Broker Non-Votes 33,025,986 




5.    To act upon a shareholder proposal requesting a report to shareholders on the effectiveness of the Company’s diversity, equity and inclusion efforts. The proposal was rejected by a vote of shareholders as follows:
For88,078,310 
Against537,661,613 
Abstain5,066,360 
Broker Non-Votes 33,025,986 

ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c)Exhibits:
Exhibit No.Description
104Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date:May 8, 2024By:/s/ James F. O'Reilly
James F. O'Reilly
Senior Vice President, Deputy General Counsel and Secretary